In a significant stride towards revolutionizing pet healthcare, FirstVet (firstvet.com) has successfully concluded a €20 million Series C funding round, bolstering its position as a leader in digital veterinary services. Founded in Stockholm in 2016, FirstVet has swiftly emerged as a pivotal platform connecting pet owners with top-tier veterinarians through innovative video consultation services. The…
A new wave of hope is washing over the oncology field with Myricx Bio’s impressive £90 million ($114 million) Series A funding. This UK biotech company, unlike its peers, isn’t taking an incremental step forward. Instead, they’re wielding a whole new weapon in the fight against cancer: N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugates (ADCs). The significance…
FREYR Battery (NYSE: FREY), a leading developer in clean, next-generation battery cell production, has reached a significant milestone in its operations with the successful completion of its first production trial at the Customer Qualification Plant (“CQP”) in Mo i Rana, Norway. This accomplishment marks FREYR as the first company to achieve automated production trials on…
When hospitals discharge patients into skilled nursing or home care, time is of the essence — yet decisions are still made using bloated PDFs, fragmented faxes, and overloaded staff. ExaCare AI believes that’s an outdated way to run one of healthcare’s most critical handoffs. Now, with a fresh $30 million Series A in hand, it’s…
TechWolf, the Belgian innovator at the forefront of AI-powered talent management, has successfully concluded a Series B funding round, raising an impressive $42.75 million. This funding marks a pivotal moment for the company as it embarks on expanding its AI infrastructure dedicated to revolutionizing employee skills management. Founded in 2018 by Andreas De Neve, Jeroen…
Rapafusyn Pharmaceuticals, a trailblazer in the realm of therapeutic drug discovery, has announced a significant milestone with the closure of a Series A financing round, amassing $28 million. This strategic investment round was led by 3E Bioventures Capital and Proxima Ventures Ltd., with participation from Lapam Capital. Rapafusyn is spearheading the development of non-degrading molecular…
In a significant boost for cancer therapy innovation, AvenCell Therapeutics, Inc. has announced the successful closure of a $112 million Series B funding round. The financing, spearheaded by Novo Holdings, attracted new investors including F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures, alongside existing backer Blackstone Life Sciences. This funding…
In a landscape crowded with large language models (LLMs) that demand enormous computational resources, MythWorx is charting a radically different course. The Dallas-based startup closed a $5 million seed round at a striking $100 million valuation—an unusually high mark for early-stage AI ventures—underscoring investor belief in its disruptive approach to artificial general intelligence (AGI). Spearheaded…
Pioneering Taiwanese AI firm APMIC is set to make waves in the U.S. market with the introduction of its advanced large language model (LLM), “CaiGunn.” As the sole Taiwanese independent software vendor endorsed by NVIDIA, APMIC is primed to elevate global enterprise AI solutions. This expansion reflects APMIC’s commitment to democratizing AI and equipping businesses…
Infinitum, a trailblazer in sustainable technology with its innovative air-core motor systems, has announced a significant boost to its Series E funding with an additional $35 million investment. This extension, led by Marunouchi Innovation Partners and Rice Investment Group, brings the total Series E funding to $220 million. The funding infusion aims to propel Infinitum’s…
